However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Additional funding could be available to promote farm products from Washington and throughout the nation under the terms of a ...

Shares of Hims and Hers (NYSE:HIMS) climbed 5% despite facing criticism over a Super Bowl advertisement for its generic weight-loss drugs. The ad, which highlights the company's more affordable ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.